Top News – Chesapeake (NYSE:CHK) , Tesla (NASDAQ:TSLA) , Federal Signal (NYSE:FSS) , Cara Therapeutics (NASDAQ:CARA) , Bankwell Financial (NASDAQ:BWFG)

Chesapeake Energy (NYSE:CHK)’s stock had its “hold” rating restated by stock analysts at Deutsche Bank in a report issued on Friday. They currently have a $33.00 price objective on the stock, up from their previous price objective of $31.00. Deutsche Bank’s target price indicates a potential upside of 22.22% from the company’s current price. Chesapeake Energy Corporation (NYSE:CHK) stock performance was 0.67% in last session … Continue reading Top News – Chesapeake (NYSE:CHK) , Tesla (NASDAQ:TSLA) , Federal Signal (NYSE:FSS) , Cara Therapeutics (NASDAQ:CARA) , Bankwell Financial (NASDAQ:BWFG)

John Meady07/2107/21

Healthcare Losers: Cara Therapeutics (NASDAQ:CARA), ERBA Diagnostics Inc (NYSEMKT:ERB), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), Concert Pharmaceuticals (NASDAQ:CNCE)

Cara Therapeutics Inc (NASDAQ:CARA) — which has a preclinical cannabis compound — jumped 11.58%. The company is clearly running (smoke) rings around the competition and has the most appropriately named spokeswoman on Earth should it wish to employ the English supermodel as a mouthpiece. Cara Therapeutics Inc (NASDAQ:CARA) stock performance was -7.49% in last session and finished the day at $14.20. Traded volume was 123,773.00million … Continue reading Healthcare Losers: Cara Therapeutics (NASDAQ:CARA), ERBA Diagnostics Inc (NYSEMKT:ERB), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), Concert Pharmaceuticals (NASDAQ:CNCE)

Richard Atkins04/2504/25